Guardian Pharmacy Services

Guardian Pharmacy Services

Founded in 2004 and headquartered in Atlanta, Fred Burke and his team assembled Guardian Pharmacy Services as a roll-up of independent long-term-care pharmacies. The company serves assisted living facilities, skilled nursing centers, and behavioral health group homes, dispensing medications and providing medication management services. Guardian went public on the New York Stock Exchange in September 2024 under the ticker GRDN. Guardian’s model combines centralized back-office functions — technology, purchasing, compliance — with locally branded pharmacies that keep their original names and community relationships. This approach covers multiple states across the Southeast and Midwest, with confirmed locations including Georgia, Florida, and South Carolina. The company’s core offering is unit-dose packaging and electronic medication administration records for facility staff, alongside consultant pharmacist reviews required by regulation. In 2023, the platform generated roughly $1.1 billion in revenue, according to its S-1 filing. The firm went public in September 2024, raising approximately $112 million in an IPO led by J.P. Morgan and Goldman Sachs (per SEC filings, 2024). Prior to the listing, Guardian was backed by private equity firms including TPG Growth. Post-IPO, Fred Burke remains CEO and the largest individual shareholder. The company does not operate a separate foundation or family-office structure; it is an operating business serving institutional healthcare customers. Guardian differs from national pharmacy chains by operating a decentralized, acquisition-driven network. Its pharmacies bill Medicare Part D, Medicaid, and private insurers under local pharmacy licenses rather than a single national entity, allowing for localized payer contracting and audit insulation that a fully centralized platform cannot replicate.